Distribution of V gene mutations in anti-HCV E2 hybridomas
| Hybridomas . | VH Germline . | Homology (%) . | R:S mutations . | Scarcity of R mutation in FRs . | Excess of R mutation in CDRs . | |
|---|---|---|---|---|---|---|
| FRs . | CDRs . | |||||
| CBH4B | VH1-69 | 90.8 | 8:8 | 9:1 | P = .00300* | P = .00925* |
| CBH4D | VH1-69 | 93.3 | 8:3 | 3:5 | P = .08676 | P = .00011* |
| CBH4G | VH1-69 | 92.9 | 5:5 | 7:3 | P = .00176* | P = .02163* |
| CBH5 | VH1-69 | 88.3 | 9:11 | 11:2 | P = .00022* | P = .00247* |
| CBH7 | VH1-69 | 90.8 | 9:10 | 6:1 | P = .00925* | P = .00019* |
| CBH8E | VH1-69 | 96.4 | 3:3 | 5:2 | P = .00691* | P = .08563 |
| CBH11 | VH1-e | 91.5 | 8:5 | 4:7 | P = .00864* | P = .00002* |
| CBH2 | VH5-51 | 94.3 | 6:4 | 6:0 | P = .04465* | P = .04465* |
| CBH8C | VH4-59 | 92.8 | 1:7 | 9:3 | P = .00001* | P = .15227 |
| CBH17 | VH3-73 | 88.8 | 11:10 | 10:1 | P = .00592* | P = .00204* |
| Hybridomas . | VH Germline . | Homology (%) . | R:S mutations . | Scarcity of R mutation in FRs . | Excess of R mutation in CDRs . | |
|---|---|---|---|---|---|---|
| FRs . | CDRs . | |||||
| CBH4B | VH1-69 | 90.8 | 8:8 | 9:1 | P = .00300* | P = .00925* |
| CBH4D | VH1-69 | 93.3 | 8:3 | 3:5 | P = .08676 | P = .00011* |
| CBH4G | VH1-69 | 92.9 | 5:5 | 7:3 | P = .00176* | P = .02163* |
| CBH5 | VH1-69 | 88.3 | 9:11 | 11:2 | P = .00022* | P = .00247* |
| CBH7 | VH1-69 | 90.8 | 9:10 | 6:1 | P = .00925* | P = .00019* |
| CBH8E | VH1-69 | 96.4 | 3:3 | 5:2 | P = .00691* | P = .08563 |
| CBH11 | VH1-e | 91.5 | 8:5 | 4:7 | P = .00864* | P = .00002* |
| CBH2 | VH5-51 | 94.3 | 6:4 | 6:0 | P = .04465* | P = .04465* |
| CBH8C | VH4-59 | 92.8 | 1:7 | 9:3 | P = .00001* | P = .15227 |
| CBH17 | VH3-73 | 88.8 | 11:10 | 10:1 | P = .00592* | P = .00204* |
| Hybridomas . | VL Germline . | Homology (%) . | R:S mutations . | Scarcity of R mutation in FRs . | Excess of R mutation in CDRs . | |
|---|---|---|---|---|---|---|
| FRs . | CDRs . | |||||
| CBH4B | Vk3-A27 | 95.4 | 3:3 | 4:2 | P = .01085* | P = .07773 |
| CBH4D | Vλ2-2a2 | 95.6 | 6:3 | 3:0 | P = .31691 | P = .24510 |
| CBH4G | Vk1-A20 | 98.5 | 0:0 | 4:0 | P = .01350* | P = .00026* |
| CBH5 | Vk1-L12 | 94.3 | 1:7 | 5:2 | P = .00001* | P = .05436 |
| CBH7 | Vk1-O12 | 96.2 | 6:2 | 1:1 | P = .89335 | P = .97264 |
| CBH8E | Vk1-O12 | 97.3 | 0:4 | 3:0 | P = .01453* | P = .42831 |
| CBH11 | Vk1-L12 | 96.2 | 1:6 | 5:0 | P = .00017* | P = .02039* |
| CBH2 | Vk3-A27 | 96.2 | 1:2 | 5:2 | P = .00110* | P = .00848* |
| CBH8C | Vk3-L6 | 98.1 | 1:1 | 3:0 | P = .05049 | P = .01699* |
| CBH17 | Vλ3-3h | 90.9 | 10:4 | 8:2 | P = .05545 | P = .01976* |
| Hybridomas . | VL Germline . | Homology (%) . | R:S mutations . | Scarcity of R mutation in FRs . | Excess of R mutation in CDRs . | |
|---|---|---|---|---|---|---|
| FRs . | CDRs . | |||||
| CBH4B | Vk3-A27 | 95.4 | 3:3 | 4:2 | P = .01085* | P = .07773 |
| CBH4D | Vλ2-2a2 | 95.6 | 6:3 | 3:0 | P = .31691 | P = .24510 |
| CBH4G | Vk1-A20 | 98.5 | 0:0 | 4:0 | P = .01350* | P = .00026* |
| CBH5 | Vk1-L12 | 94.3 | 1:7 | 5:2 | P = .00001* | P = .05436 |
| CBH7 | Vk1-O12 | 96.2 | 6:2 | 1:1 | P = .89335 | P = .97264 |
| CBH8E | Vk1-O12 | 97.3 | 0:4 | 3:0 | P = .01453* | P = .42831 |
| CBH11 | Vk1-L12 | 96.2 | 1:6 | 5:0 | P = .00017* | P = .02039* |
| CBH2 | Vk3-A27 | 96.2 | 1:2 | 5:2 | P = .00110* | P = .00848* |
| CBH8C | Vk3-L6 | 98.1 | 1:1 | 3:0 | P = .05049 | P = .01699* |
| CBH17 | Vλ3-3h | 90.9 | 10:4 | 8:2 | P = .05545 | P = .01976* |
The probability (P) that excess or scarcity of replacement (R) mutations in CDRs and in FRs resulted only by chance was calculated using the multinominal distribution model.24
Significant.